News Image

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Provided By PR Newswire

Last update: Aug 27, 2024

Results Support Future Study of the Hemopurifier® as Part of a Machine Perfusion Circuit to Further Assess its Association with Function of Retrieved Kidneys

Read more at prnewswire.com

AETHLON MEDICAL INC

NASDAQ:AEMD (2/21/2025, 8:00:08 PM)

After market: 0.6199 +0.04 (+6.26%)

0.5834

-0.03 (-4.25%)



Find more stocks in the Stock Screener

Follow ChartMill for more